ABIOMED Inc. (ABMD) |
|
260.48 -1.66 (-0.63%)
|
05-17 16:00 |
|
Open: |
260.74 |
Pre. Close: |
262.14 |
|
High:
|
262.95 |
Low:
|
256 |
|
Volume:
|
542,521 |
Market Cap:
|
11754M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
263.1 - 264.444 |
264.444 - 265.474 |
|
Low:
|
252.884 - 254.29 |
254.29 - 255.368 |
|
Close:
|
258.24 - 260.614 |
260.614 - 262.434 |
|
|
|
Technical analysis |
as of: 2019-05-17 4:26:27 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 329.08 One year: 384.37 |
| Support: |
Support1: 248.53 Support2: 228.00 |
| Resistance: |
Resistance1: 281.75 Resistance2: 329.08 |
| Pivot: |
264.56 |
| Moving Average: |
MA(5): 258.27  MA(20): 265.27
MA(100): 309.74 MA(250): 352.48 |
| MACD: |
MACD(12,26): -6.75 Signal(9): -7.67 |
| Stochastic oscillator: |
%K(14,3): 60.96 %D(3): 57.37 |
| RSI: |
RSI(14): 42.01 |
| 52-week: |
High: 459.75 Low: 228.00 Change(%): -32.2 |
| Average Vol(K): |
3-Month: 75885 10-Days: 76940 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ABMD has closed above bottom band by 36.0%. Bollinger Bands are 37.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 14 May 2019 14:14:49 Z
ABIOMED's Impella 5.0 and LD Receive Expanded FDA Approvals
Mon, 13 May 2019 08:14:30 Z
Abiomed and Intersect ENT Stumble to Start 2019
Fri, 10 May 2019 23:00:25 Z
ShockWave Medical's Revenue Soars in Its Public Debut
Fri, 10 May 2019 17:59:33 Z
2 Winners and 2 Losers in the Med Tech Market This Quarter
Thu, 02 May 2019 23:09:00 Z
ABIOMED Inc. (ABMD) Q4 2019 Earnings Call Transcript
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. (M) |
45.12 |
| Shares Float (M) |
42.07 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
2.720 |
|
EPS Est. Current Year
|
2.330 |
|
EPS Est. Next Year
|
2.670 |
|
EPS Est. Next Quarter
|
0.560 |
|
Forward EPS
|
3.290 |
|
Book Value (p.s.)
|
12.620 |
|
PEG Ratio
|
2.03 |
|
Profit Margin
|
33.66 |
|
Operating Margin
|
29.22 |
|
Return on Assets (ttm)
|
28.1 |
|
Return on Equity (ttm)
|
31.9 |
|
Qtrly Rev. Growth
|
18.7 |
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
100.70 |
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
P/E
|
95.76 |
|
P/E Growth Ratio
|
-0.01 |
|
P/BV
|
20.64 |
|
P/S
|
686097920.00 |
|
P/CF
|
|
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
